{"title":"Laparoscopic dismembered pyeloplasty for ureteropelvic junction obstruction in children: a single-surgeon experience.","authors":"Thuy Nguyen Thi Mai, Thao Nguyen Phuong","doi":"10.3389/fped.2026.1735651","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The objective of this work is to evaluate the safety and short-term outcomes of laparoscopic dismembered pyeloplasty (LDP) for ureteropelvic junction obstruction (UPJO) in children, based on a single-surgeon experience using a transabdominal suspension technique.</p><p><strong>Methods: </strong>We retrospectively analyzed children with UPJO between January 2023 and October 2024 who underwent transperitoneal LDP with a transabdominal suspension maneuver performed by a single surgeon. The diagnosis was confirmed by ultrasonography and magnetic resonance urography. The outcomes were operative time, complications, hospital stay, and postoperative hydronephrosis reduction, assessed by ultrasonography at least 3 months after the operation.</p><p><strong>Results: </strong>A total of 60 children with a mean age of 58.5 months (range: 6-168 months) underwent surgery during the study period; of these, 47 were boys. The mean operative time was 140 min (range: 120-200 min). No open conversions or major complications occurred. The mean hospital stay was 3.5 days. The median pelvic diameter decreased from 35.6 mm (range: 25-50 mm) preoperatively to 13.5 mm (range: 8-22 mm) postoperatively (<i>p</i> < 0.05). All patients were free from symptoms with reduced hydronephrosis during the follow-up period.</p><p><strong>Conclusions: </strong>Transperitoneal laparoscopic dismembered pyeloplasty is a safe and effective option in the treatment of UPJO, and a transabdominal suspension technique may facilitate the procedure.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"14 ","pages":"1735651"},"PeriodicalIF":2.2000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13079668/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Pediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fped.2026.1735651","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The objective of this work is to evaluate the safety and short-term outcomes of laparoscopic dismembered pyeloplasty (LDP) for ureteropelvic junction obstruction (UPJO) in children, based on a single-surgeon experience using a transabdominal suspension technique.
Methods: We retrospectively analyzed children with UPJO between January 2023 and October 2024 who underwent transperitoneal LDP with a transabdominal suspension maneuver performed by a single surgeon. The diagnosis was confirmed by ultrasonography and magnetic resonance urography. The outcomes were operative time, complications, hospital stay, and postoperative hydronephrosis reduction, assessed by ultrasonography at least 3 months after the operation.
Results: A total of 60 children with a mean age of 58.5 months (range: 6-168 months) underwent surgery during the study period; of these, 47 were boys. The mean operative time was 140 min (range: 120-200 min). No open conversions or major complications occurred. The mean hospital stay was 3.5 days. The median pelvic diameter decreased from 35.6 mm (range: 25-50 mm) preoperatively to 13.5 mm (range: 8-22 mm) postoperatively (p < 0.05). All patients were free from symptoms with reduced hydronephrosis during the follow-up period.
Conclusions: Transperitoneal laparoscopic dismembered pyeloplasty is a safe and effective option in the treatment of UPJO, and a transabdominal suspension technique may facilitate the procedure.
期刊介绍:
Frontiers in Pediatrics (Impact Factor 2.33) publishes rigorously peer-reviewed research broadly across the field, from basic to clinical research that meets ongoing challenges in pediatric patient care and child health. Field Chief Editors Arjan Te Pas at Leiden University and Michael L. Moritz at the Children''s Hospital of Pittsburgh are supported by an outstanding Editorial Board of international experts. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Frontiers in Pediatrics also features Research Topics, Frontiers special theme-focused issues managed by Guest Associate Editors, addressing important areas in pediatrics. In this fashion, Frontiers serves as an outlet to publish the broadest aspects of pediatrics in both basic and clinical research, including high-quality reviews, case reports, editorials and commentaries related to all aspects of pediatrics.